53 pending office actions • 33 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19274087 | O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES | Novaliq GmbH | YU, HONG | 1614 | Non-Final OA | Jul 18, 2025 |
| 18691876 | BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR | Montelino Therapeutics, Inc. | SHI, GENBIN | 1628 | Non-Final OA | Mar 13, 2024 |
| 18691875 | BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR | Montelino Therapeutics, Inc. | NESTOR, DONNA MICHELLE | 1627 | Non-Final OA | Mar 13, 2024 |
| 18596349 | NOVEL METHODS | Intra-Cellular Therapies, Inc. | STEVENS, MARK V | 1613 | Non-Final OA | Mar 05, 2024 |
| 18405616 | COSMETIC COMPOSITIONS COMPRISING POLYETHER POLYMERS | P2 Science, Inc. | GULLEDGE, BRIAN M | 1699 | Non-Final OA | Jan 05, 2024 |
| 18575201 | METHODS OF TREATMENT | Diffusion Pharmaceuticals LLC | SHIM, DAVID M. | 1626 | Non-Final OA | Dec 28, 2023 |
| 18567743 | NOVEL SALTS AND CRYSTALS | Intra-Cellular Therapies, Inc. | RODRIGUEZ, RAYNA B | 1628 | Non-Final OA | Dec 06, 2023 |
| 18564378 | PHARMACEUTICAL COMPOSITION FOR TREATING BRAIN DISEASES COMPRISING ANTIBODY SPECIFICALLY BINDING TO ASM PROTEIN AS ACTIVE INGREDIENT | Kyungpook National University Industry-Academic Cooperation Foundation | STEPHENS, AMELIA CAROLE | 1645 | Non-Final OA | Nov 27, 2023 |
| 18505264 | RUXOLITINIB CRYSTAL AND PHARMACEUTICAL COMPOSITION THEREOF | Zhejiang Ausun Pharmaceutical Co., Ltd. | HABTE, KAHSAY | 1624 | Non-Final OA | Nov 09, 2023 |
| 18504472 | BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR | Montelino Therapeutics, Inc. | COLEMAN, BRENDA LIBBY | 1624 | Non-Final OA | Nov 08, 2023 |
| 18555198 | SAFE HARBOR LOCI FOR CELL ENGINEERING | Hangzhou Qihan Biotech Co., Ltd. | CORDAS, EMILY ANN | 1632 | Non-Final OA | Oct 12, 2023 |
| 18377756 | STABILISED PROTEIN COMPOSITIONS BASED ON SEMIFLUORINATED ALKANES | Novaliq GmbH | KOSACK, JOSEPH R | 3991 | Non-Final OA | Oct 06, 2023 |
| 18550088 | THE OXIDATION OF CARBON-HYDROGEN BONDS USING OZONE | P2 Science, Inc. | CUTLIFF, YATE KAI RENE | 1692 | Non-Final OA | Sep 11, 2023 |
| 18463715 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | Genequantum Healthcare (Suzhou) Co., Ltd. | HUYNH, PHUONG N | 1641 | Non-Final OA | Sep 08, 2023 |
| 18549446 | Anti-HER2 Antibody-Immune Agonist Conjugate and Applications Thereof | Brightgene Bio-Medical Technology Co., Ltd. | STONEBRAKER, ALYSSA RAE | 1642 | Non-Final OA | Sep 07, 2023 |
| 18548719 | Method of Evaluating the Biofilm Detachment Efficacy of Compositions | The Ohio State University | SWIFT, CANDICE LEE | 1657 | Non-Final OA | Sep 01, 2023 |
| 18548833 | TRIAZOLYL-METHYL SUBSTITUTED ALPHA-D-GALACTOPYRANOSIDE DERIVATIVES | Idorsia Pharmaceuticals Ltd. | CHO, DAVID H | 1693 | Non-Final OA | Sep 01, 2023 |
| 18460334 | NOVEL FLUOROCHEMICAL CARDIAC RESUSCITATION | NuvOx Pharma LLC | WEDDINGTON, KEVIN E | 1629 | Non-Final OA | Sep 01, 2023 |
| 18450240 | ORAL CARE PRODUCTS AND METHODS | BASF Corporation | ROBERTS, LEZAH | 1612 | Final Rejection | Aug 15, 2023 |
| 18263318 | CRYSTALLINE FORM OF A PIPERAZINYL-THIAZOLE DERIVATIVE | Idorsia Pharmaceuticals Ltd. | ROMERO, KRISTEN WANG | 1624 | Non-Final OA | Jul 27, 2023 |
| 18265400 | METHOD FOR CONSTRUCTING STRICTLY ANAEROBIC SALMONELLA, CONSTRUCTED STRICTLY ANAEROBIC SALMONELLA AND APPLICATION THEREOF | Shenzhen Synthetica Pioneering Co., Ltd. | LYONS, MARY M | 1645 | Non-Final OA | Jun 05, 2023 |
| 18253694 | METHOD FOR TREATING TUMOURS BY CAPTURING COPPER AND/OR IRON | Institut National De Recherche Pour L'Agriculture, L'Alimentation Et L'Environnement | PALENIK, JEFFREY T | 1615 | Final Rejection | May 19, 2023 |
| 18253586 | METHOD FOR PREPARING NANOPARTICLES | Centre National De La Recherche Scientifique - Cnrs - | CRAIG, KAILA ANGELIQUE | 1618 | Non-Final OA | May 18, 2023 |
| 18308288 | INHIBITORS OF ENPP1 AND MODULATION OF BONE GROWTH | Petragen, Inc. | SEAMAN, D MARGARET M | 1625 | Non-Final OA | Apr 27, 2023 |
| 18249728 | NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME | Tme Therapeutics LLC | NOLAN, JASON MICHAEL | 1623 | Final Rejection | Apr 19, 2023 |
| 18299657 | NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME | Tme Therapeutics LLC | CHANDRAKUMAR, NIZAL S | 1625 | Non-Final OA | Apr 12, 2023 |
| 18029518 | Prebiotic Oral Care Compositions and Methods | UNIVERSITEIT GENT | LIU, TRACY | 1614 | Non-Final OA | Mar 30, 2023 |
| 18043959 | NOVEL SALTS, CRYSTALS, AND CO-CRYSTALS | Intra-Cellular Therapies, Inc. | SHOWALTER, ALEXANDER KEITH | 1629 | Final Rejection | Mar 03, 2023 |
| 18172618 | PROTECTIVE FORMULATIONS | Unknown | ALAM, AYAAN A | 1611 | Final Rejection | Feb 22, 2023 |
| 18042103 | ORGANIC COMPOUNDS | Intra-Cellular Therapies, Inc. | FETTEROLF, BRANDON J | 1626 | Non-Final OA | Feb 17, 2023 |
| 18040618 | PHARMACEUTICAL COMPOSITION OF AQUAPORIN INHIBITOR AND PREPARATION METHOD THEREOF | Aeromics, Inc. | ARNOLD, ERNST V | 1613 | Final Rejection | Feb 03, 2023 |
| 18156865 | RECOMBINANT VARIANTS OF R-SPONDIN PROTEINS AND THEIR USE | Centre National De La Recherche Scientifique (Cnrs) | CHANDRA, GYAN | 1674 | Non-Final OA | Jan 19, 2023 |
| 18156749 | SEMIFLUORINATED ALKANE COMPOSITIONS | Novaliq GmbH | HOWELL, THEODORE R | 1628 | Non-Final OA | Jan 19, 2023 |
| 18152110 | SYSTEMS AND METHODS FOR WRITING, READING, AND CONTROLLING DATA STORED IN A POLYMER | Iridia, Inc. | WOOLWINE, SAMUEL C | 1681 | Non-Final OA | Jan 09, 2023 |
| 18066883 | METHODS OF TREATMENT WITH S1P RECEPTOR MODULATORS | Priothera Limited | SHOWALTER, ALEXANDER KEITH | 1629 | Non-Final OA | Dec 15, 2022 |
| 18001764 | NOVEL ISOMERIC COMPOUNDS COMPRISING A RING-OPENED THIOSUCCINIMIDE GROUP, AN OLIGOPEPTIDE FRAGMENT AND A CHIRAL MOIETY | Genequantum Healthcare (Suzhou) Co., Ltd. | NGUYEN, TAM M | 1771 | Non-Final OA | Dec 14, 2022 |
| 18062246 | ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS | H. Lundbeck A/S | DOLETSKI, BLAINE G | 1692 | Final Rejection | Dec 06, 2022 |
| 18057650 | SYSTEMS AND METHODS FOR WRITING, READING, AND CONTROLLING DATA STORED IN A POLYMER | Iridia, Inc. | KOVACH, KARA NICOLE | 1681 | Non-Final OA | Nov 21, 2022 |
| 17996276 | USE OF AN ORPHAN MOTIF TO INCREASE EXPRESSION OF A HETEROLOGOUS TRANSGENE | Friedrich Miescher Institute For Biomedical Research | HORTH, LISA ANNE | 1681 | Non-Final OA | Oct 14, 2022 |
| 17995810 | ANTI-CD47 ANTIBODY AND USES THEREOF | Hutchison Medipharma Limited | MOSELEY II, NELSON B | 1642 | Final Rejection | Oct 07, 2022 |
| 17917337 | USE OF BROMODOMAIN INHIBITORS FOR TREATMENT OF HUNTINGTON'S DISEASE | Rumi Scientific Holdings, Inc. | SIMMONS, CHRIS E | 1622 | Final Rejection | Oct 06, 2022 |
| 17995220 | THE USE OF DIFFUSION ENHANCING COMPOUNDS FOR TREATMENT OF VIRAL AND BACTERIAL INDUCED RESPIRATORY DISEASE | Diffusion Pharmaceuticals LLC | THOMAS, TIMOTHY P | 1614 | Non-Final OA | Sep 30, 2022 |
| 17910720 | IL-10 MUTEINS | Centre Hospitalier Régional Universitaire De Lille | MERTZ, PREMA MARIA | 1674 | Non-Final OA | Sep 09, 2022 |
| 17757572 | NOVEL USES | Intra-Cellular Therapies, Inc. | HSU, GRACE CHING | 1627 | Non-Final OA | Jun 17, 2022 |
| 17832282 | ORGANIC COMPOUNDS | Intra-Cellular Therapies, Inc. | DRAPER, LESLIE A ROYDS | 1629 | Non-Final OA | Jun 03, 2022 |
| 17831796 | Oral Care Products and Methods | BASF Corporation | ARNOLD, ERNST V | 1613 | Non-Final OA | Jun 03, 2022 |
| 17673480 | Prebiotic Oral Care Compositions and Methods | UNIVERSITEIT GENT | PETRITSCH, AMANDA MICHELLE | 1612 | Non-Final OA | Feb 16, 2022 |
| 17579559 | PARTICLE SEPARATOR SYSTEM, MATERIALS, AND METHODS OF USE | Levitasbio, Inc. | SPANGLER, JOSEPH RANKIN | 1656 | Non-Final OA | Jan 19, 2022 |
| 17613832 | OPHTHALMIC COMPOSITION FOR THE TREATMENT OF OCULAR ALLERGY | Novaliq GmbH | BRADLEY, CHRISTINA | 1654 | Final Rejection | Nov 23, 2021 |
| 17350427 | SEMIFLUORINATED COMPOUNDS | Novaliq GmbH | MOU, LIYUAN | 1628 | Non-Final OA | Jun 17, 2021 |
| 17297580 | SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING OMEGA-3 FATTY ACID ETHYL ESTERS | Novaliq GmbH | MCKOY, QUINCY ANDRE | 1626 | Non-Final OA | May 27, 2021 |
| 17279518 | NOVEL USES | Intra-Cellular Therapies, Inc. | CHENG, KAREN | 1623 | Final Rejection | Mar 24, 2021 |
| 17127867 | METHODS OF SCHIZOPHRENIA TREATMENT | Intra-Cellular Therapies, Inc. | LEE, ANDREW P | 1691 | Non-Final OA | Dec 18, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial